Literature DB >> 3129350

Serial observation of lymphocyte subpopulations and interleukin 2 production of T cells from patients with acute viral hepatitis and chronic active hepatitis.

M Onji1, H Kondo, Y Ohta.   

Abstract

T cell subpopulations and interleukin 2 (IL-2) production of T cells in peripheral blood from patients with acute viral hepatitis (AVH) and chronic active hepatitis (CAH) were studied to elucidate the change of T cells functions during the exacerbation of viral hepatitis. The ratio of the number of CD4-positive cells to CD8-positive cells (CD:CD8 ratio) was increased in many patients with AVH. During exacerbation of CAH, the CD4:CD8 ratio was higher than that during remission (p less than 0.01), due to a decrease in the number of CD8-positive cells. IL2 production of T cells in AVH and CAH with bridging necrosis was higher than that of T cells in normal controls (p less than 0.01, p less than 0.05, respectively). T cells from patients with CAH produced more IL2 during exacerbation than during remission (p less than 0.01). IL2 production of T cells and the CD4:CD8 ratio (p less than 0.005, p less than 0.01). The change in T cell subpopulations in AVH and during exacerbation of CAH was found to induce an immunological condition, in which T cells easily produce IL2, which induces a proliferation of cytotoxic T cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3129350

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  2 in total

1.  Expression rate of cytokine mRNA in the liver of chronic hepatitis C: comparison with chronic hepatitis B.

Authors:  R Fukuda; S Satoh; X T Nguyen; Y Uchida; N Kohge; S Akagi; S Ikeda; M Watanabe; S Fukumoto
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

2.  Two-dimensional flow cytometric analysis of intrahepatic lymphocyte subsets from patients with chronic hepatitis.

Authors:  T Takehara; N Hayashi; K Katayama; A Kasahara; H Fusamoto; M Kato; M Masuzawa; T Kamada
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.